ecancer

The p-medicine project and ECRIN

Jacques Demotes - ECRIN

2 Sep 2015

Highlights of the p-medicine project

2 Sep 2015

Psychological support for patients with CML

Dr Silvia Riva - University of Milan, Milan, Italy

17 Aug 2015

Genetics and epigenetics of lymphocyte development and transformation

Dr Stefano Casola - IFOM University of Milan, Milan, Italy

27 Jul 2015

New emerging treatments in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro

7 Jul 2015

TargomiRs show promise in phase I study of malignant mesothelioma

Prof Nico van Zandwijk - University of Sydney, Sydney, Australia

3 Jul 2015

Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL

Dr Paula Cramer - University of Cologne, Köln, Germany

30 Jun 2015

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA

19 Jun 2015

Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands

$Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )$

17 Jun 2015

EHA 2015 highlights

Peter Goodwin - ecancer reporter

17 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK

16 Jun 2015

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK

16 Jun 2015

More from ecancer